No Data
No Data
RheinBio (002166.SZ): The overall gross margin for the whole year is expected to remain within a relatively reasonable margin of 25-30%
Gelonghui, April 29丨RheinBio (002166.SZ) held an online exchange on April 26, 2024 to discuss “Based on the first quarter results, does the company have performance guidelines for the full year 2024?” The company replied that in terms of revenue, we will continue to maintain a 15% -20 growth forecast after considering possible quarterly performance fluctuations. In terms of profit, judging by the gross margin level in the first quarter and the price trend of raw materials this year, the overall gross margin for the whole year is expected to remain within a relatively reasonable margin range of 25-30%.
Rheinbio (002166.SZ): Currently, the construction of the synthetic biology plant has entered a relatively advanced stage, and it is expected to be put into use in the third quarter
Gelonghui April 29 丨 Rheinland Biotech (002166.SZ) held an online exchange on April 26, 2024, about “What are the company's latest developments in the synthetic biology business?” The company replied that the construction of the synthetic biology plant has now entered a relatively advanced stage and is expected to be put into use in the third quarter. In terms of research and development, R&D projects for full synthesis and enzymatic transformation technology are progressing normally, and phased results have been achieved. In particular, projects to produce some high-value natural sweetener ingredients through enzymatic conversion technology have passed pilot tests, and can be quickly put into production after the factory is completed.
Rheinbio: Price trends for stevia and Luo Han Guo extract products are expected to increase this year
When surveyed by an agency recently, Rhine Biotech said that it is now the end of April, and the cultivation of raw materials has basically come to an end. Judging from the raw material cultivation situation currently available, it is expected that the prices of stevia extract and Luo Han Guo extract products will be an upward trend this year, especially Luo Han Guo extract. The price of raw materials is expected to gradually recover to an even price this year, which in turn will drive up some of the prices of downstream products.
RheinBio (002166.SZ): Net profit of 267.901 million yuan in the first quarter increased by 34.37% year-on-year
Gelonghui, April 26 | Rhine Biotech (002166.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 341 million yuan, up 35.07% year on year; net profit attributable to shareholders of listed companies was 267.91 million yuan, up 34.37% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 395.709 million yuan, up 372.05% year on year; basic earnings per share were 0.04 yuan.
RheinBio (002166.SZ): The company has not cooperated with cannabis production and processing companies
Gelonghui, April 18 | Rhine Biotech (002166.SZ) said on the investor interactive platform that the company has not yet cooperated with cannabis production and processing companies.
RheinBio (002166.SZ): The company's industrial hemp factory mainly produces CBD and derivatives and other related products
Gelonghui, April 18 | Rhine Biotech (002166.SZ) said on the investor interactive platform that the company's industrial hemp factory mainly produces CBD and related products such as derivatives.
No Data